Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.1956

IVF after recurrent breast cancer: is it ethical? A Case Report

Part of Topic

Reproductive medicine/assisted reproduction

Title: IVF After Recurrent Breast Cancer: is it Ethical? A Case Report
 
Case Summary:
•42-year-old Asian woman presents to Recurrent Miscarriage (RM) Clinic with 2 previous 1st trimester miscarriages and subfertility (>2 years to conceive)
•History of breast cancer 2017 and breast cancer recurrence 2020. In remission from recurrence for 3 years.
•Maintenance tamoxifen therapy, stopped herself to try and conceive.
•Oestrogen and Progesterone receptor positive cancer, HER2 negative
•RM bloods all within normal range
•In vitro fertilisation (IVF) would be the optimum chance of successful conception (6% with own eggs - improved odds with donor eggs).
•Concerns raised by fertility, RM and breast team regarding IVF impact on recurrence risk.
•Already at a 5% risk of recurrence due to stopping tamoxifen already.

 

‘Would IVF and the hormonal treatment required increase her risk of breast cancer recurrence?’

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.